Levetiracetam Extended-Release Tablets are the generic version of Keppra XR of UCB.
Keppra is an anti-epileptic drug which is indicated for the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.
Actavis is engaged in the development, manufacture and sale of generic pharmaceuticals.